Active Public Health & Healthcare

Polypharmacy and the impact of antidepressants, antipsychotics and benzodiazepines on falls and fractures risks in older adults: a triangulation approach towards causal inference for the study of drug combinations

In plain English

AI plain-English summary

Older adults taking combinations of antidepressants, antipsychotics and benzodiazepines are falling and fracturing bones at higher rates, but it remains unclear whether the drugs themselves cause these injuries or whether the underlying conditions are to blame. This matters because millions of older people take these medications, and clinical guidelines currently lack robust evidence on the risks of using them together. The problem is that standard observational studies struggle to separate the drug’s effect from the effect of the illness it treats—someone prescribed an antidepressant may already be at higher fall risk due to depression itself. The researcher will use three different causal inference methods—a target trial framework, a self-controlled case series, and mendelian randomization—each with different strengths, to triangulate whether the drug combinations actually cause falls and fractures. If successful, this work could directly change prescribing guidelines for geriatric and psychiatric care. Doctors would have clearer information about which drug combinations carry the highest risk, and patients could make more informed choices about their medications. The impact would be felt in everyday clinical decisions and in the design of safer prescribing regimens for older adults.

View original technical description
I aim to use evidence from different causal inference study designs that rely on different assumptions and have differing strengths and limitations to evaluate combination use of antidepressants, antipsychotics and benzodiazepines on risks of falls and fractures in older adults. This will include use of the target trial framework, an appropriate self-controlled method (e.g., case cross-over or self-controlled case series) and mendelian randomization. The target trial approach can clarify the causal question of interest and account for biases introduced by analysis decisions such as immortal time bias, whereas the self-controlled design can better control for time-invariant confounding because it is a within-individual design. Mendelian randomization can allow assessment of the on-target and off-target effects of drugs and their corresponding indications on falls and fractures. The population of interest is older adults aged 40 years and above who have prescription records of an antidepressant, antipsychotic and/or benzodiazepine. Confounding and selection bias will be accounted for using appropriate analysis methods. I anticipate that results from this study will inform clinical guidelines, improve geriatric and psychiatric care, and help provide patients with informed choice about medications.

View the original record at the funder ↗

Researchers

Aaron Jun Yi Yap (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Prevention and management of multimorbidity and polypharmacy (changed to: Medication use in older people: exploring the relationship between polypharmacy and socioeconomic inequalities)
Antihypertensive interventions in older adults: estimating benefits and risks in clinical datasets
An evidence synthesis suite to inform a future randomised trial of reducing anticholinergic related harm in older adults
Exploring biases in propensity score analyses of Electronic Health Record (EHR) data
STRatifying Antihypertensive Treatments In multi-morbid hypertensives For personalised management of Blood Pressure (STRATIFY-BP)

Original classification

PhD Studentship (Basic)

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.